A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W

Lonza

Company-logo  COMPANY DETAILS
Lonza
Muenchensteinerstrasse 38
Basel
4002
Switzerland

Website
Mail
Call
  +41 61 316 8111


Printer
  +41 61 316 9111

HEALTH CATEGORIES

mobility; sports nutrition


Facebook   
Linkedin   
Twitter   
Youtube   

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment. 

Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries. 

Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fast-moving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources. 

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com.

Additional Information and Disclaimer

Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.

Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.



Articles On NutritionInsight
FormattedPicture

NUTRITION & HEALTH NEWS

Lonza’s new kimichi-derived sports nutrition probiotic addresses clean label demands

18 Sep 2020 --- Lonza is launching its first probiotic ingredient for the sports nutrition market. TWK10 is a Lactobacillus plantarum probiotic strain that has been clinically shown to improve... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

COVID-19 updates

16 Sep 2020 --- Throughout the global COVID-19 pandemic, NutritionInsight is dedicated to bringing its readers all the latest and most relevant industry updates. Visit this regularly-updated news... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Healthy aging not just about seniors, say Vitafoods 2020 exhibitors

08 Sep 2020 --- The healthy aging sector has developed to include more than just senior consumer groups. Ranging from acute pain relief to long-term heart and bone health, various interpretations... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Chr. Hansen targets “different path” with expansion of microbial capacities

25 Aug 2020 --- Chr. Hansen’s new 2025 strategy will see more investments in the expansion of its microbial platform and technological capabilities. Notably, the Denmark-based company is... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

Healthy aging: Innova Market Insights reveals rising holistic nutrition demands

25 Aug 2020 --- Consumers are increasingly seeking a more holistic approach to healthy aging, according to a new Innova Market Insights survey. The research reveals that seven out of ten consumers... Read More




Videos
FormattedPicture

Titanium dioxide-free semi-opacifier reaches market ahead of French ban

02 Jan 2020 --- Lonza launched Vcaps Plus White Opal, its first commercially-available titanium dioxide-free semi-opaque capsule for food supplements, at CPhI Worldwide 2019. The launch precedes a ban on titanium dioxide, set to come into force in France, 2020. Stéphane Vouche, Marketing Manager at Lonza, predicts that increased scrutiny is bound to increase demand for clean label solutions in the space – something the new product offers with its avoidance of unnecessary chemicals, plasticizers and other elements.

FormattedPicture

Clean label capsule launch

14 May 2019 --- At Vitafoods Europe 2019, Lonza launched its new Vcaps Plus White Opal capsule in a bid to address the growing demand for opaque capsules that do not include titanium dioxide. NutritionInsight spoke with Dominik Mattern, Associate Director Business Development, Head of Business Development, Lonza, about the new launch as well as the company's clean label platform.

FormattedPicture

Total solutions for personal care formulations

25 Apr 2019 --- At In-cosmetics Global 2019 in Paris, Lonza exhibited a number of concepts, including SYNETH, a series of polyglycerol esters. Each fiber offers a unique and innovative texture and aesthetic for the personal, intimate, body and oral care spaces. Jennifer Clancy notes that Lonza is offering turn-key solutions in personal care and beauty and providing consumers with a fully holistic view of health and wellness. 

FormattedPicture

Addressing clean label supplement demands

11 Feb 2019 --- Lonza recently revealed the global launch of its latest dosage form innovation: Capsugel Vcaps Plus plant-based capsules. The first of the next-generation clean label solutions to be marketed worldwide is the Vcaps Plus Purple Carrot capsule, following the successful introduction of the Vcaps Plus Blue Spirulina capsule in Europe earlier this year. The high-performance capsule shell is made using plant-based hypromellose (HPMC) and water only, without any preservatives. A colorant derived from purple carrots is used to match the desired shade as closely as possible, while maintaining a natural appearance in the finished supplement. Achieving unique visual appeal, the purple carrot color also provides masking capabilities.

FormattedPicture

Innovating in ready-to-market formulations

17 Jan 2019 --- Stephane Vouche, of Lonza Capsugel, spoke to NutritionInsight at Health Ingredients Europe (HiE) in 2018 on innovating in ready-to-market formulations. Vouche shared that Lonza was presenting new formulations at the show. One particular innovation included a combination capsule with Lonza's UCT-II ingredient for joint health with curcumin. This combination creates a powerful one-pill solution, meaning consumers do not need to take multiple pills, Vouche said.




Articles On The World of Food Ingredients
FormattedPicture

THE WORLD OF FOOD INGREDIENTS

Opinion Edge: Trends in Supplements and Nutritionals

18 Aug 2020 --- Key suppliers offer their thoughts on the nutritionals industry. Which formats, flavors, and active ingredients are consumers seeking in “the new normal”?




Nutrition Focus
FormattedPicture
08 Jun 2020 | Lonza

Busy consumers embrace supplements

While differing generations have unique nutritional priorities, they share a desire to live healthy and less stressed lives. This has led many to turn to supplements as an easy way to... Read More

FormattedPicture
24 Oct 2019 | Lonza

Clean label remains king for supplements amid consumer safety concern

Clean label remains king in the supplement space, as consumers who are wary of ingredient traceability and safety are drawn to shorter label lists. Concerns from consumers and lobby groups... Read More

FormattedPicture
18 Mar 2019 | Lonza

Moving with the times: A new generation joint health solution for today’s consumer

The aging consumer has growing expectations of bone and joint health solutions, thanks to the mainstreaming of sports nutrition and a growing focus on active aging. According to Innova... Read More

FormattedPicture
02 Oct 2018 | Lonza

Bone and joint health: Increased focus on mobility and healthy aging

Products featuring bone & joint health claims are on the rise, with Innova Market Insights data showing a compound annual growth rate of 13 percent between 2013 and... Read More




Webinars
FormattedPicture

Live Better: Feel good, Stay mobile. Formulation strategies for today’s consumer

24 Jun 2020 --- Supplement users increasingly aspire to more sustainable, health-focused ideals and are on the hunt for high-quality, responsibly sourced products that help them to stay mobile and live better. In this webinar, Lonza experts delve into how these preferences extend across a range of emerging, on-demand consumer trends, from joint and cognitive health to probiotics and beauty-from-within.

FormattedPicture

Tio2 free: Clear path to compliance

08 Nov 2019 --- This webinar will discuss how food supplement makers can address the rising consumer demand for clean and clear label solutions in light of the changing regulatory environment regarding the use of titanium dioxide as an opacifier. It will also explore how Lonza’s new Vcaps® Plus WHITE OPAL® capsule is designed to perform and can support producers to meet this growing need in today’s market.

FormattedPicture

Moving with the times: a new generation joint health solution for today’s consumer

28 Mar 2019 --- The NutritionInsight webinar “Moving with the times: a new generation joint health solution for today’s consumer” offers insights into the changing consumer landscape, including the expectations of both aging and active consumers and rising demand for joint health solutions. Dominik Mattern of Lonza Capsugel discusses the science behind Lonza’s UC-II undenatured type II collagen ingredient, including its unique mode of action and how it can meet the needs of a new and growing consumer base. He presents a first look at Lonza’s new generation of ready-to-market innovative dosage forms and formulations that address mobility concerns related to healthy aging.

FormattedPicture

Driving growth in the joint health category: UC-II® undenatured type II collagen

19 Oct 2018 --- UC-II® undenatured type II collagen is a once-a-day joint health solution for the joint health market. Its small dose size and mode of action help make it the preferred choice among top food supplement manufacturers and retailers. Learn why UC-II® undenatured type II collagen is a success story and discover new ready-to-market solutions.

FormattedPicture

L-Carnitine – discover new market opportunities

06 Feb 2018 --- First utilized as an essential ingredient in infant nutrition, the market potential of L-Carnitine has evolved in recent years to now provide beneficial support across multiple product categories. L-Carnitine is enjoying significant growth of almost 31 percent in food and beverages with sports-related claims when comparing 2012 and 2017 launch activity. Further innovation is taking place as the mainstreaming of sports nutrition accelerates.




A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W